Thrombosis Research Institute, India Contact Number, Contact Details

Published date: July 18, 2021
Unique Id of VO/NGOKA/2018/0218087

Thrombosis Research Institute, India Registration Details

Registered WithSub-Registrar
Type of NGOTrust (Non-Government)
Registration NoBNG(U)ANKL.S.R/D.No.117/03-04
Copy of Registration CertificateAvailable
Copy of Pan CardAvailable
Act nameTRUST ACT
City of RegistrationBANGALORE
State of RegistrationKARNATAKA
Date of Registration18-11-2003

Thrombosis Research Institute, India Members

NameDesignationPanAadhaar
Devi Prasad ShettyChairmanAvailableAvailable
PRAVIN KUMAR HOSABETTUSecretaryAvailableAvailable
Sharat DamodarTreasurerAvailableAvailable

Thrombosis Research Institute, India Sector/ Key Issues

Key IssuesEducation & Literacy
Operational Area-StatesKARNATAKA
Operational Area-DistrictKARNATAKA->Bangalore

Thrombosis Research Institute, India FCRA details

FCRA AvailableFCRA Registration no.
Available094421073

Thrombosis Research Institute, India Details of Achievements

The Indian Atherosclerosis Research Study has enrolled 10 606 subjects Genetic Epidemiological studies have focussed on identifying key gene polymorphisms for developing a predictive genetic risk score. Biomarker Discovery program identified 8 novel biomarkers with potential to do risk prediction for coronary artery disease The Vaccine Development program Identification of an oral route of vaccine administration which can induce high level of tolerance to self antigens Oral administration o

Thrombosis Research Institute, India Source of Funds

Department NameSourceFinacial YearAmount SanctionedPurpose
DSTCentral2015-2016600000• Screening and identifying the miRNAs expression involved at different stages of disease progression in mouse model using Microarray analysis • Validating the expression levels of miRNAs using Quantitative Real time- PCR • Identifying target specific role of miRNA using Bioinformatic approach. • Antisense-Mediated miRNA knockdown: antimiRNA conjugated to a cholesterol moiety bind to the target miRNA which inhibits its expression. Administration of antimiRNA and optimizing the dosage
TRI LondonOverseas2015-20167785582Grant for Administration expenses for TRI Bangalore
DSTCentral2016-2017450000• Antisense-Mediated miRNA knockdown: antimiRNA conjugated to a cholesterol moiety bind to the target miRNA which inhibits its expression. Administration of antimiRNA and optimizing the dosage • Efficacy testing of targeted miRNA for stabilizing or controlling the disease development in mouse model. • In vitro studies measuring the inflammatory response in spleen cells, Dendritic cells, T cells, B cells including surface and intracellular markers after treatment using flow cytometry.
TRI LondonOverseas2016-20173403008Grant for Administration expenses of TRI Bangalore
TRI LondonOverseas2017-20181731905Grant for Administration expenses of TRI Bangalore
Not SpecifiedAny Other2018-2019Not SpecifiedNo grant received

Thrombosis Research Institute, India Contact Details

AddressTHROMBOSIS RESEARCH INSTITUTE, INDIA NO.258/A, NARAYANA HRUDAYALAYA BOMMASANDRA INDUSTRIAL AREA ANEKAL TALUK
CityBANGALORE
StateKARNATAKA
TelephoneNot Available
Mobile No9742444100
Website UrlNot Available
E-mailhenshon@gmail.com

Related listings

Feedback / Rewiews

    Leave your comment (spam and offensive messages will be removed)